In a phase 1 study of 10 adults with advanced retinitis pigmentosa, researchers found that optogenetic gene therapy combined ...
Dr. Shy's decades of work have helped identify CMT genes and establish research networks, while he has cared for ...
Jacque Duncan, MD, reviews phase 3 DRAGON data on oral tinlarebant for Stargardt disease and its mechanism-related visual ...
Chico Enterprise-Record on MSN
Enloe Health to receive $9M to expand cell, gene therapy access
Enloe Health announced Monday that was selected to receive a $9 million grant from the California Institute for Regenerative ...
A multicenter real-world study found that first-line trastuzumab deruxtecan doubled progression-free survival compared with ...
Editas Medicine (EDIT) downgraded to Hold as it pivots to in vivo CRISPR EDIT-401; timeline and cash runway into 2H 2028.
A Hong Kong model compared upfront NGS with EGFR/ALK-first testing in metastatic NSCLC, highlighting trade-offs in cost, ...
T-MAXIMUM PHARMACEUTICAL ("T-MAXIMUM") today announced that the U.S. Food and Drug Administration (FDA) has cleared the ...
Known for its freezing winters, Finland is warming up to global entrepreuners and investors to boost its life science ...
The FDA has approved 'Otarmeni', the first gene therapy for congenital hearing loss (DFNB9) caused by OTOF gene mutations.It ...
A Bengaluru infant diagnosed with Spinal Muscular Atrophy at just five weeks old has successfully received gene replacement ...
Dublin, Oct. 12, 2026 (GLOBE NEWSWIRE) -- "Preclinical Imaging - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)" has been added to ResearchAndMarkets.com's offering.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results